These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1083 related items for PubMed ID: 10388502

  • 1. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A.
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [Abstract] [Full Text] [Related]

  • 2. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [Abstract] [Full Text] [Related]

  • 3. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
    Delladetsima I, Psichogiou M, Sypsa V, Psimenou E, Kostakis A, Hatzakis A, Boletis JN.
    Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R.
    N Engl J Med; 1996 Mar 28; 334(13):815-20. PubMed ID: 8596547
    [Abstract] [Full Text] [Related]

  • 5. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 28; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 6. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
    Rostaing L, Izopet J, Arnaud C, Rumeau JL, Duffaut M, Cisterne JM, Durand D.
    Nephrologie; 1999 Sep 28; 20(3):165-70. PubMed ID: 10418007
    [Abstract] [Full Text] [Related]

  • 7. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
    Fabrizi F, Lunghi G, Marai P, Marcelli D, Guarnori I, Raffaele L, Erba G, Pagano A, Locatelli F.
    Nephrol Dial Transplant; 1996 Jan 28; 11(1):159-64. PubMed ID: 8649626
    [Abstract] [Full Text] [Related]

  • 8. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
    Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL.
    Hepatology; 1996 Nov 28; 24(5):1041-6. PubMed ID: 8903372
    [Abstract] [Full Text] [Related]

  • 9. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
    Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT.
    Am J Gastroenterol; 2002 Feb 28; 97(2):478-83. PubMed ID: 11866292
    [Abstract] [Full Text] [Related]

  • 10. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.
    Z Gastroenterol; 1997 Apr 28; 35(4):255-61. PubMed ID: 9163889
    [Abstract] [Full Text] [Related]

  • 11. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
    Minz M, Sharma A, Das A, Chawla Y.
    Transplant Proc; 2008 Sep 28; 40(7):2386-8. PubMed ID: 18790242
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B, Assis D, Caldwell C, Arvelakis A, Taddei T, Kulkarni S, Schilsky M, Emre S.
    Transplant Proc; 2011 Apr 28; 43(3):905-8. PubMed ID: 21486625
    [Abstract] [Full Text] [Related]

  • 13. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK, Makris F, Psichogiou M, Kostakis A, Hatzakis A, Boletis JN.
    Liver; 2001 Apr 28; 21(2):81-8. PubMed ID: 11318976
    [Abstract] [Full Text] [Related]

  • 14. Serial measurements of hepatitis C viral load by real-time polymerase chain reaction among recipients of living-donor renal transplants: a short-term follow-up study from a single center.
    Justa S, Minz RW, Minz M, Sharma A, Anand S, Das A, Chawla YK, Sakhuja VK.
    Transplant Proc; 2010 Nov 28; 42(9):3568-73. PubMed ID: 21094817
    [Abstract] [Full Text] [Related]

  • 15. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB, Liang JT, Chu JS, Chen KM, Lee CS.
    Hepatogastroenterology; 1995 Nov 28; 42(6):913-8. PubMed ID: 8847045
    [Abstract] [Full Text] [Related]

  • 16. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr 28; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 17. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK.
    Hepatology; 1996 Nov 28; 24(5):1003-9. PubMed ID: 8903367
    [Abstract] [Full Text] [Related]

  • 18. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
    Martin P, Busuttil RW, Goldstein RM, Crippin JS, Klintmalm GB, Fitzsimmons WE, Uleman C.
    Liver Transpl; 2004 Oct 28; 10(10):1258-62. PubMed ID: 15376310
    [Abstract] [Full Text] [Related]

  • 19. Experience of fibrosing cholestatic hepatitis with hepatitis C virus in kidney transplant recipients.
    Siddiqui AR, Abbas Z, Luck NH, Hassan SM, Aziz T, Mubarak M, Naqvi SA, Rizvi SA.
    Transplant Proc; 2012 Apr 28; 44(3):721-4. PubMed ID: 22483477
    [Abstract] [Full Text] [Related]

  • 20. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
    Berenguer M, Prieto M, Palau A, Rayón JM, Carrasco D, Juan FS, López-Labrador FX, Moreno R, Mir J, Berenguer J.
    Liver Transpl; 2003 Mar 28; 9(3):228-35. PubMed ID: 12619018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.